Jove
Visualize
Contact Us

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Disorders of Hemostasis01:24

Disorders of Hemostasis

707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Coagulation01:09

Coagulation

4.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

4.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Clinical Reasoning in Surgical Education: A Randomized Crossover Trial on AI-Generated Individual Feedback for Key Feature Question-Based Online Assignments.

Journal of surgical education·2026
Same author

ActiTect: a generalizable machine learning pipeline for REM sleep behavior disorder screening through standardized actigraphy.

NPJ digital medicine·2026
Same author

Reciprocal Relationship Between Cardiovascular Risk and Attainment of Blood Pressure and Cholesterol Targets in Users of a Mobile Health App.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same author

Smartphone Sensor Battery Consumption: A Standardized and Reproducible Test Protocol.

Sensors (Basel, Switzerland)·2026
Same author

Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Fully Anonymized Digital Health Data Acquisition in a Research Partnership Using a Blinded Deidentification Proxy in the HerzFit App: Implementation Study.

JMIR formative research·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 5, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review.

Fabian Kahl1, Maximilian Kapsecker1,2, Leon Nissen1

  • 1Institute for Digital Medicine, University Hospital Bonn, Bonn, Germany.

Hamostaseologie
|December 10, 2024
PubMed
Summary

Digital technologies, including artificial intelligence (AI), are increasingly used for hereditary blood disorders. While AI aids diagnosis and treatment, more intervention studies are needed to fully realize their potential in managing these conditions.

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

11.6K

Related Experiment Videos

Last Updated: Jun 5, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

11.6K

Area of Science:

  • Hematology
  • Medical Informatics
  • Digital Health

Background:

  • Systematic review of digital technologies in hereditary blood coagulation disorders.
  • Focus on prevention, diagnosis, and treatment applications.
  • Addresses hemophilia A, hemophilia B, and von Willebrand disease.

Approach:

  • PRISMA guidelines followed for systematic review.
  • PubMed search conducted January 29, 2024.
  • Inclusion criteria: 2014-present, English, actual digital tool application, hereditary coagulation disorders, human data (≥3 subjects).

Key Points:

  • 21 articles met inclusion criteria from 2,843 initial searches.
  • 12 articles focused on artificial intelligence (AI); 9 on digital applications.
  • AI predominantly used for diagnosis and treatment; digital applications mainly for treatment.

Conclusions:

  • Growing use of AI and digital applications in managing hereditary coagulation disorders.
  • AI enhances diagnostic accuracy and treatment personalization.
  • Digital applications improve patient care and engagement, but further research is needed due to study limitations.